sacituzumab,trastuzumab deruxtecan
gilead sciences,Daiichi Sankyo,AstraZeneca
['sacituzumab']
learn the pro outcome of sacituzumab and traztuzumab deruxtecan. #esmo22 
MD Anderson Cancer Ctr, Breast Med Oncologist, Section Chief of Translational Breast Cancer Research, Executive Director of IBC Program